COSTA MESA, Calif.--(BUSINESS WIRE)--ProteomTech, Inc. (www.proteomtech-inc.com) announced today that the Company and its collaborators have successfully generated induced pluripotent stem (iPS) cells from somatic cells using recombinant proteins, thereby creating an economical and expeditious way to generate stem cells while simultaneously eliminating any risk of modifying the target cell genome. It was the first study ever to report that iPS cells can be generated without the use of any form of exogenous genetic material. The study was published online today in the journal Cell Stem Cell.
